KRABD4
gene geneOn this page
Also known as FLJ20344
Summary
KRABD4 (KRAB domain containing 4, HGNC:26007) is a protein-coding gene on chromosome Xp11.3, encoding KRAB domain-containing protein 4 (Q5JUW0).
This encodes a zinc finger protein with an N-terminal KRAB (Kruppel-associated) domain found in transcriptional repressors. This gene is located in a region of the X chromosome thought to be involved in nonsyndromic X-linked cognitive disability. Multiple transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 55634 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_001129898
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26007 |
| Approved symbol | KRABD4 |
| Name | KRAB domain containing 4 |
| Location | Xp11.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20344 |
| Ensembl gene | ENSG00000147121 |
| Ensembl biotype | protein_coding |
| OMIM | 300585 |
| Entrez | 55634 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 26 protein_coding, 1 retained_intron
ENST00000298190, ENST00000344302, ENST00000377919, ENST00000464900, ENST00000476762, ENST00000478600, ENST00000487081, ENST00000901194, ENST00000901195, ENST00000901196, ENST00000901197, ENST00000901198, ENST00000901199, ENST00000901200, ENST00000901201, ENST00000901202, ENST00000901203, ENST00000901204, ENST00000901205, ENST00000932354, ENST00000932355, ENST00000932356, ENST00000932357, ENST00000942304, ENST00000942305, ENST00000942306, ENST00000942307
RefSeq mRNA: 4 — MANE Select: NM_001129898
NM_001129898, NM_001129899, NM_001129900, NM_017776
CCDS: CCDS14267, CCDS48097, CCDS48098
Canonical transcript exons
ENST00000344302 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001093022 | 46450431 | 46450475 |
| ENSE00001635850 | 46462748 | 46462874 |
| ENSE00001743364 | 46463198 | 46463308 |
| ENSE00001772329 | 46448200 | 46448310 |
| ENSE00001819311 | 46472750 | 46474639 |
| ENSE00001886612 | 46447297 | 46447346 |
Expression profiles
Bgee: expression breadth ubiquitous, 243 present calls, max score 86.57.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.3630 / max 177.2784, expressed in 1772 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196119 | 11.6251 | 1763 |
| 196120 | 1.0124 | 699 |
| 196118 | 0.7255 | 430 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of uterus | UBERON:0009853 | 86.57 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 86.55 | gold quality |
| cerebellar cortex | UBERON:0002129 | 86.51 | gold quality |
| cortical plate | UBERON:0005343 | 86.49 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 86.34 | gold quality |
| left ovary | UBERON:0002119 | 86.21 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.08 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 86.01 | gold quality |
| adrenal tissue | UBERON:0018303 | 85.94 | gold quality |
| right lobe of liver | UBERON:0001114 | 85.93 | gold quality |
| endocervix | UBERON:0000458 | 85.88 | gold quality |
| nucleus accumbens | UBERON:0001882 | 85.83 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 85.68 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 85.67 | gold quality |
| right ovary | UBERON:0002118 | 85.58 | gold quality |
| cerebellum | UBERON:0002037 | 85.55 | gold quality |
| visceral pleura | UBERON:0002401 | 85.49 | gold quality |
| spleen | UBERON:0002106 | 85.47 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 85.44 | gold quality |
| thyroid gland | UBERON:0002046 | 85.42 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.35 | gold quality |
| ovary | UBERON:0000992 | 85.09 | gold quality |
| right coronary artery | UBERON:0001625 | 85.09 | gold quality |
| colonic epithelium | UBERON:0000397 | 85.08 | gold quality |
| right uterine tube | UBERON:0001302 | 84.89 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 84.89 | gold quality |
| lower esophagus | UBERON:0013473 | 84.88 | gold quality |
| parietal pleura | UBERON:0002400 | 84.86 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 84.86 | gold quality |
| omental fat pad | UBERON:0010414 | 84.82 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.30 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
91 targeting KRABD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-4525 | 99.94 | 64.38 | 675 |
| HSA-MIR-5010-5P | 99.94 | 64.11 | 705 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp78 | ENSMUSG00000055150 |
| rattus_norvegicus | ENSRNOG00000083797 | |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
KRAB domain-containing protein 4 — Q5JUW0 (reviewed: Q5JUW0)
Alternative names: KRAB box domain-containing protein 4
All UniProt accessions (3): Q5JUW0, C9J804, C9J950
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Expressed in brain, ovary, testis, prostate, tonsil, heart, bone marrow, colon, breast and kidney.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5JUW0-1 | 1 | yes |
| Q5JUW0-2 | 2 | |
| Q5JUW0-3 | 3 |
RefSeq proteins (4): NP_001123370, NP_001123371, NP_001123372, NP_060246 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR050169 | Krueppel_C2H2_ZnF | Family |
Pfam: PF01352
UniProt features (6 total): splice variant 3, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JUW0-F1 | 49.11 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-73857 | RNA Polymerase II Transcription |
| R-HSA-74160 | Gene expression (Transcription) |
MSigDB gene sets: 69 (showing top):
WANG_CISPLATIN_RESPONSE_AND_XPC_DN, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, chrXp11, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, ZWANG_DOWN_BY_2ND_EGF_PULSE, MTOR_UP.N4.V1_DN, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZIM3_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Gene expression (Transcription) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| binding | 1 |
Protein interactions and networks
STRING
638 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRABD4 | CHST7 | Q9NS84 | 950 |
| KRABD4 | SLC9A7 | Q96T83 | 881 |
| KRABD4 | ZNF391 | Q9UJN7 | 638 |
| KRABD4 | ZNF449 | Q6P9G9 | 623 |
| KRABD4 | TCEANC | Q8N8B7 | 447 |
| KRABD4 | PPP1R2C | O14990 | 437 |
| KRABD4 | ZNF18 | P17022 | 429 |
| KRABD4 | ZNF492 | Q9P255 | 418 |
| KRABD4 | DUSP21 | Q9H596 | 405 |
| KRABD4 | DIPK2B | Q9H7Y0 | 397 |
| KRABD4 | ZNF711 | Q9Y462 | 393 |
| KRABD4 | EFHC2 | Q5JST6 | 372 |
| KRABD4 | GEMIN8 | Q9NWZ8 | 352 |
| KRABD4 | ARMCX2 | Q7L311 | 348 |
| KRABD4 | ZKSCAN4 | Q969J2 | 348 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| KRBOX4 | ASXL2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (21): SLC25A1 (Affinity Capture-MS), STX3 (Affinity Capture-MS), TTC3 (Affinity Capture-MS), SLC25A11 (Affinity Capture-MS), KIAA0355 (Affinity Capture-MS), TRIM28 (Affinity Capture-MS), SLC43A3 (Affinity Capture-MS), SLC35F6 (Affinity Capture-MS), ASXL2 (Affinity Capture-MS), XPO5 (Affinity Capture-MS), C8orf33 (Affinity Capture-MS), SLC25A22 (Affinity Capture-MS), TMEM126A (Affinity Capture-MS), GADD45GIP1 (Affinity Capture-MS), FAM58A (Affinity Capture-MS)
ESM2 similar proteins: A0RZ79, A2BYT2, A2C4Z5, A8SEE4, A9A5W9, A9BCP3, A9CB83, B2XWR4, B4RL59, B7HHG6, B7HKD5, C4K7B4, C6Y4A2, G2TRU4, O28329, O29734, O29982, O74973, P03715, P38465, P39495, P41072, P41392, P62393, P83002, P84990, P86291, Q18LD6, Q2YAV1, Q3J6Q0, Q3MFB7, Q3V4Z3, Q46IR3, Q537H7, Q54J26, Q58525, Q5F861, Q5JUW0, Q5SD12, Q5UPH6
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 15 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1332 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:46462835:G:T | donor_gain | 1.0000 |
| X:46462914:G:GG | donor_gain | 1.0000 |
| X:46463196:AG:A | acceptor_gain | 1.0000 |
| X:46463197:GG:G | acceptor_gain | 1.0000 |
| X:46462742:TTACA:T | acceptor_loss | 0.9900 |
| X:46462743:TACA:T | acceptor_loss | 0.9900 |
| X:46462744:ACAGG:A | acceptor_loss | 0.9900 |
| X:46462747:G:A | acceptor_loss | 0.9900 |
| X:46462835:G:GT | donor_gain | 0.9900 |
| X:46463194:ACAG:A | acceptor_gain | 0.9900 |
| X:46463196:A:AG | acceptor_gain | 0.9900 |
| X:46463196:AGG:A | acceptor_gain | 0.9900 |
| X:46463197:G:GC | acceptor_gain | 0.9900 |
| X:46463197:GGG:G | acceptor_gain | 0.9900 |
| X:46463197:GGGT:G | acceptor_gain | 0.9900 |
| X:46472748:A:AG | acceptor_gain | 0.9900 |
| X:46472749:G:GG | acceptor_gain | 0.9900 |
| X:46472749:GAA:G | acceptor_gain | 0.9900 |
| X:46447347:G:GG | donor_gain | 0.9800 |
| X:46447361:G:GT | donor_gain | 0.9800 |
| X:46448020:G:GT | donor_gain | 0.9800 |
| X:46462741:ATTAC:A | acceptor_loss | 0.9800 |
| X:46462746:A:AG | acceptor_gain | 0.9800 |
| X:46462747:G:GG | acceptor_gain | 0.9800 |
| X:46462747:GGA:G | acceptor_gain | 0.9800 |
| X:46462834:G:GT | donor_gain | 0.9800 |
| X:46462871:GTGG:G | donor_gain | 0.9800 |
| X:46463195:CA:C | acceptor_loss | 0.9800 |
| X:46463197:G:A | acceptor_loss | 0.9800 |
| X:46447344:G:GT | donor_gain | 0.9700 |
AlphaMissense
1131 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:46462781:T:C | F17L | 0.975 |
| X:46462783:C:A | F17L | 0.975 |
| X:46462783:C:G | F17L | 0.975 |
| X:46462848:A:T | E39V | 0.973 |
| X:46462782:T:C | F17S | 0.969 |
| X:46462819:G:C | Q29H | 0.967 |
| X:46462819:G:T | Q29H | 0.967 |
| X:46462796:T:A | W22R | 0.964 |
| X:46462796:T:C | W22R | 0.964 |
| X:46462827:T:C | L32P | 0.961 |
| X:46462874:G:T | G48W | 0.959 |
| X:46462798:G:C | W22C | 0.956 |
| X:46462798:G:T | W22C | 0.956 |
| X:46462822:G:C | K30N | 0.955 |
| X:46462822:G:T | K30N | 0.955 |
| X:46462760:T:C | F10L | 0.952 |
| X:46462762:C:A | F10L | 0.952 |
| X:46462762:C:G | F10L | 0.952 |
| X:46462849:G:C | E39D | 0.952 |
| X:46462849:G:T | E39D | 0.952 |
| X:46462852:C:A | N40K | 0.950 |
| X:46462852:C:G | N40K | 0.950 |
| X:46462772:T:C | F14L | 0.946 |
| X:46462774:T:A | F14L | 0.946 |
| X:46462774:T:G | F14L | 0.946 |
| X:46462843:G:A | M37I | 0.944 |
| X:46462843:G:C | M37I | 0.944 |
| X:46462843:G:T | M37I | 0.944 |
| X:46462806:T:C | L25P | 0.938 |
| X:46462863:T:C | L44P | 0.938 |
dbSNP variants (sampled 300 via entrez): RS1000290993 (X:46469167 G>A), RS1000700967 (X:46456325 A>G), RS1000897773 (X:46471885 C>A), RS1000913500 (X:46462934 C>T), RS1001025559 (X:46449644 A>G), RS1001446773 (X:46448802 G>A), RS1001550458 (X:46451026 CATCTT>C), RS1001692869 (X:46446431 G>A), RS1001703186 (X:46458044 G>A), RS1001755561 (X:46457705 A>C,G,T), RS1001853440 (X:46448548 C>G), RS1001916128 (X:46452038 C>T), RS1001954775 (X:46474002 C>T), RS1001991518 (X:46446822 G>A), RS1002285846 (X:46447707 G>A)
Disease associations
OMIM: gene MIM:300585 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002403_714 | Red blood cell count | 4.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004305 | erythrocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | increases expression | 2 |
| dicrotophos | decreases expression | 1 |
| geraniol | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| K 7174 | increases expression | 1 |
| abrine | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Estradiol | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Valproic Acid | affects expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.